Search
Publications
Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial
P. Sonneveld, A. Chanan-Khan, K. Weisel, A. K. Nooka, T. Masszi, M. Beksac, I. Spicka, V. Hungria, M. Munder, M.
How to apply to be an SWG member
A step-by-step guide to applying for specialized working group (SWG) membership. 1. Go to the EHA PortalTo apply for an SWG, you must be registered on the EHA Portal.
Read morePublications
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry
Aiello TF, Salmanton-Garcia J, Marchesi F, et al. Haematologica. 2024 Aug 1;109(8):2693-2700.
“Complement-ing” positive outcomes during the COVID-19 pandemic
Dr Dimitrios Mastellos (@dmastellos)
The COVID-19 pandemic has had a huge impact on research worldwide. Multiple projects have been halted and researchers have lost their jobs.
Challenging the safety of conformity: Better poster design to disseminate scientific knowledge fast
“Congratulations – your abstract was accepted for the upcoming EHA congress”.
Read moreI4MDS consortium: advancing MDS treatment and understanding
The role of the immune system in the pathophysiology of Myelodysplastic Neoplasms (MDS) is firmly established. However, routine immune monitoring for these patients is still not a common practice.
Read moreSponsors
If you want to go fast, go alone. If you want to go far, go together. We aim for long-term relationships with our partners and sponsors.
Read moreHow to apply for CBTH
TimelinesApplication CBTH 2025
Deadline: September 24, 2024 (15:00 CEST)
Notification
November 2024
How to apply?Download the signature letter template. Fill in the template and get it duly signed for upload into the online application platform.